EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Sequential and Systemic Administration of BMP-2 and SDF-1α Nanocapsules for Promoting Osteoporotic Fracture Healing

Xiaolei Sun, Xueping Li, Peng Tian, Jin Zhao, Hou Xin iD, Xinlong Ma, Xubo Yuan

Biomimetics · 16.08.2023 · 8 (4) · 369

DOI: 10.3390/biomimetics8040369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomimetics, online erschienen am 16.08.2023. Verfasst von Xiaolei Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and Engineering, Tianjin University, Tianjin 300072, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Nature Science Foundation of China, National Nature Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to investigate the use of the nanocapsule sequential delivery of BMP-2 and SDF-1α through the peripheral circulatory system to promote the healing of osteoporotic fractures.

Methods

Based on increased vascular permeability in the early hematoma environment around the fracture and the presence of a large number of matrix metalloproteinase MMPs in the inflammatory environment, we designed MMP-sensitive nanocapsules which were formed viain situ free-radical polymerization on the surface of grow factors with 2-(methacryloyloxy) ethyl phosphorylcholine (MPC) and the bisacryloylated VPLGVRTK peptide. The antiphagic effect and biological activity of the growth factors for the nanomicrocapsule delivery system were tested by cell experiments. The 36 SD rats with an osteoporotic fracture model were randomly divided into six groups (A, B, C, D, E, and F). In this paper, the nanocapsules loaded with BMP-2 and SDF-1 are represented as n (BMP-2) and n (SDF-1α). In the six groups, the following different combinations of growth factors were injected into the bone defect site on days 1 and 3 after bone defect surgery: in group A, n (SDF-1α) combined with n (SDF-1α); in group B, n (BMP-2) combined with n (BMP-2); in group C, n (SDF-1α) + n (BMP-2) combined with n (SDF-1α) + n (BMP-2); in group D, n (SDF-1α) combined with n (BMP-2); in group E, n (BMP-2) combined with n (SDF-1α); in group F, nanocapsules without growth factor were used as the control group. Micro-CT was used to observe the effect of n(BMP-2) and n(SDF-1α) sequential delivery inearly healing in osteoporotic fractures. Finally, in this study, we evaluated the safety of the nanocapsules delivery system by detecting ectopic osteogenesis and inflammatory responses in animals.

Results

Nanocapsules have low toxicity and protect the integrity and biological activity of growth factors. The results confirmed that nanocapsules could still be effectively targeted to the fracture site on days 1, 3, and 7 after intravenous administration. Growth factors encapsulated in nanocapsules have better bone repair results than natural growth factors. In particular, groups C and D had the best bone repair results than other groups.In vivo experiments confirmed that nanocapsules did not cause significant ectopic osteogenesis and inflammation.

Conclusion

The results confirmed that the special vascular permeability and inflammatory factor microenvironment of the fracture site could be used to deliver two growth factors with a synergistic effect through venous circulation, which could better promote the healing process of osteoporotic fracture.

Schlagwörter

Stichwörter der Autor:innen

BMP-2SDF-1αnanocapsulesosteoporotic fracturesystemic administration

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and Engineering, Tianjin University, Tianjin 300072, China.
  • Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
  • Department of Orthopaedics, Tianjin Hospital, Tianjin 300211, China.
  • Tianjin Hospital, Tianjin University, No. 406 Jiefang South Road, Tianjin 300211, China.

ORCID-Profile: Hou Xin

Förderung

  • the National Nature Science Foundation of China
  • National Nature Science Foundation of China

Zitieren

APA

Sun, X., Li, X., Tian, P., Zhao, J., Xin, H., Ma, X., & Yuan, X. (2023). The Sequential and Systemic Administration of BMP-2 and SDF-1α Nanocapsules for Promoting Osteoporotic Fracture Healing. Biomimetics, 8(4), 369. https://doi.org/10.3390/biomimetics8040369

Vancouver

Sun X, Li X, Tian P, Zhao J, Xin H, Ma X, et al. The Sequential and Systemic Administration of BMP-2 and SDF-1α Nanocapsules for Promoting Osteoporotic Fracture Healing. Biomimetics. 2023;8(4):369. doi:10.3390/biomimetics8040369

BibTeX
@article{Sun2023,
  author = {Sun, Xiaolei and Li, Xueping and Tian, Peng and Zhao, Jin and Xin, Hou and Ma, Xinlong and Yuan, Xubo},
  title = {The Sequential and Systemic Administration of BMP-2 and SDF-1α Nanocapsules for Promoting Osteoporotic Fracture Healing},
  journal = {Biomimetics},
  year = {2023},
  volume = {8},
  number = {4},
  pages = {369},
  doi = {10.3390/biomimetics8040369}
}
Kostenlos starten →